EMCURE latest shareholding pattern: promoter holding, FII / FPI holding, DII and mutual fund holding, public holding and number of shareholders, quarter by quarter.
As of Sep 2026, promoters held 77.82% of Emcure Pharmaceuticals Ltd, FIIs 4.94%, DIIs 8.49%, government - and the public 8.75%, across 1,29,328 shareholders.